Special Issue "Vaccine Strategies for Women"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines and Society".

Deadline for manuscript submissions: 1 December 2023 | Viewed by 994

Special Issue Editors

Department of Global Health and Development, London School of Hygiene and Tropical Medicine (LSHTM), 15-17, Tavistock Place London, London WC1H 9SH, UK
Interests: social aspects of health (with a particular focus on HIV); poverty; inequality; migration and mobility and the study of diversity
Special Issues, Collections and Topics in MDPI journals
Africa Health Research Institute, KwaZulu-Natal, South Africa
Interests: social aspects of health (with a particular focus on HIV); poverty; inequality; migration and mobility and the study of diversity
Africa Health Research Institute, KwaZulu-Natal, South Africa
Interests: social aspects of health (with a particular focus on HIV); poverty; inequality; migration and mobility and the study of diversity

Special Issue Information

Dear Colleagues,

In the development of new vaccination strategies communicating with those who are to receive the vaccine is crucial. Telling the public about vaccines, why they are needed and by whom can encourage uptake. For some groups, pregnant and lactating women for example, there may be a particular need for customised information that is sensitive to the women and their families concerns about the effect of the vaccine on the child. `Women’ are not a homogenous group, it is therefore, important that vaccine strategies acknowledge difference, and tailor approaches to different places and context. The aim of this issue is to collect contributions on vaccine strategies to reach women of different ages, ethnicities, socio-economic status and religious beliefs. We aim to provide evidence to contribute to the tailoring of existing strategies to meet women’s needs and the development of future vaccine strategies.

We welcome papers about vaccine strategies, particularly in lower and middle income countries, for:

  • Girls and young women
  • Pregnant and lactating women
  • Older women
  • Women from different socioeconomic/ethnic groups
  • COVID-19 vaccination strategies and women
  • Women living with a disability

Prof. Dr. Janet Seeley
Dr. Rujeko Samanthia Chimukuche
Dr. Busisiwe Nkosi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • women
  • girls
  • vaccine
  • vaccination
  • lower and middle income countries
  • Africa
  • Asia
  • Latin America

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

Brief Report
Policy and Guideline Review of Vaccine Safety for COVID-19 in Pregnant Women in Southern Africa, with a Particular Focus on South Africa
Vaccines 2022, 10(12), 2077; https://doi.org/10.3390/vaccines10122077 - 05 Dec 2022
Viewed by 824
Abstract
Pregnant and lactating mothers have historically been excluded from clinical trials. To understand the shift from excluding to including this population in COVID-19 vaccine trials, we conducted a review of guidance issued by countries in southern Africa over the last three years. We [...] Read more.
Pregnant and lactating mothers have historically been excluded from clinical trials. To understand the shift from excluding to including this population in COVID-19 vaccine trials, we conducted a review of guidance issued by countries in southern Africa over the last three years. We conducted a review of documents and official statements recorded on Ministries of Health websites, and social media platforms, the World Health Organisation website, the COVID-19 Maternal Immunisation tracker and the African Union official webpage. Search terms included COVID-19 vaccination policies, guidelines for pregnant and lactating women, COVID-19 vaccination trials and pregnant women. We retrieved and reviewed policies, guidelines, and official statements from 12 countries. We found inconsistencies and incomplete guidance in respect to the inclusion of pregnant and lactating mothers in COVID-19 vaccine trials from the selected countries. Of the twelve countries reviewed, Namibia and South Africa had clear guidance on vaccination plans and implementation for pregnant women, and their inclusion in COVID-19 vaccine trials. Explicit and clear guidelines are critical in communicating changes in policy towards those deemed vulnerable for them to participate in vaccine trials. This review provides lessons for future pandemics on managing changes in guidance towards those groups historically excluded from vaccine and clinical trials. Full article
(This article belongs to the Special Issue Vaccine Strategies for Women)
Show Figures

Figure 1

Back to TopTop